Validity, reliability, responsiveness, and clinically meaningful change threshold estimates of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)
This study provides evidence that the NFBSI-16 has desirable psychometric properties for use in clinical studies in aBC. It also provides estimates of group- and individual-level meaningful change thresholds to facilitate score interpretation in future aBC research.
Authors
- Anders Ingelgård
- Ingolf Griebsch (ORCID: https://orcid.org/0000-0002-6631-0955)
- David F Cella (ORCID: https://orcid.org/0000-0002-9881-4541)
- Nathan A. Clarke (ORCID: https://orcid.org/0000-0002-8636-1872)
- Brendon Wong (ORCID: https://orcid.org/0000-0003-1559-3841)
- Andrew Trigg (ORCID: https://orcid.org/0000-0002-1613-8042)
- Rachael Lawrance (ORCID: https://orcid.org/0000-0002-9499-8443)
Institutions
- Northwestern University (US)
- Boehringer Ingelheim (Germany) (DE)
- Adelphi Group (United Kingdom) (GB)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1186/s41687-024-00776-y
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00